Skip to main content

MoneyWorks4Me

Shilpa Medicare informs about disclosure

09 Aug 2023 Evaluate
Shilpa Medicare has informed that it enclosed disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August 09, 2023 for Ramakant Innani, on behalf of Promoters.

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..